Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05570604 · ClinicalTrials.gov registry record · NA

Computerized Cognitive Training in Breast Cancer Survivors

A NA study of Breast Cancer and Quality of Life, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT05570604 is a NA study of Breast Cancer and Quality of Life that has completed, run by Ohio State University. The registered enrollment target is 46 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05570604, a NA study of Breast Cancer and Quality of Life, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

For millions of cancer survivors, cognitive impairment is a prevalent, severe, and persistent problem that is associated with other symptoms (depressive symptoms, anxiety and fatigue), poorer work ability, and poorer quality of life. Available evidence, including work by the investigators own group, suggests that cognitive training may be a viable treatment option. However, to date, these studies are limited as none have been conducted in the home and therefore fail to address the transferability of these empirically based cognitive training programs to general practice. The purpose of this translational research is to conduct a home based single-blind, randomized controlled trial to test the feasibility, satisfaction, and preliminary efficacy of cognitive training compared to attention control in breast cancer survivors (BCS) as well as to explore potential biomarkers of intervention effects. This research innovatively builds on investigator's previous research by: 1) translating findings from the laboratory to the home setting and importantly seeks to identify facilitators and barriers of intervention use; 2) addresses limitations of previous trials (uses an attention control rather than a no-contact or wait-list control), (3) examines cognitive training effects on real-life outcomes such as associated symptoms, perceived work ability and quality of life; and (4) will be the first study in cancer survivors to explore levels of BDNF as a potentially sensitive outcome measure of intervention effects over time compared to attention control. Findings from this study will provide necessary information about the feasibility, satisfaction and preliminary efficacy of the home-based cognitive training on memory performance and processing speed as well as its effects on associated outcomes in BCS. Positive results will lead to a larger, full-scale study to determine efficacy and build evidence-based treatment for clinicians to use in treating BCS with cognitive impairment

Interventions

  • BEHAVIORAL Sweep Seeker
  • BEHAVIORAL Bird Safari
  • BEHAVIORAL Jewel Diver
  • BEHAVIORAL Master Gardener
  • BEHAVIORAL Road Tour

Study Locations (1)

Indiana

  • Indiana University School of Nursing - Indianapolis

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2017-05-17
Est. Completion 2020-03-20
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05570604

The ClinicalTrials.gov registry entry for NCT05570604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Sweep Seeker is the first listed.

NCT05570604 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05570604 about?

NCT05570604 is a clinical study titled "Computerized Cognitive Training in Breast Cancer Survivors". For millions of cancer survivors, cognitive impairment is a prevalent, severe, and persistent problem that is associated with other symptoms (depressive symptoms, anxiety and fatigue), poorer work ability, and poorer quality of life. Available evidence, including work by the investigators own group,...

What is the current status of trial NCT05570604?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2017-05-17. Estimated completion is 2020-03-20.

What conditions does trial NCT05570604 study?

This clinical trial studies the following conditions: Breast Cancer, Quality of Life, Cognitive Impairment, Cognitive Change.

What interventions are being tested in trial NCT05570604?

The interventions under investigation include: Sweep Seeker (BEHAVIORAL), Bird Safari (BEHAVIORAL), Jewel Diver (BEHAVIORAL), Master Gardener (BEHAVIORAL), Road Tour (BEHAVIORAL).

Who is sponsoring clinical trial NCT05570604?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05570604 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.